CYP46A1 and juvenile Huntington disease: As a case in point, a recent study shows that the expression of Cyp46a1 is decreased in the striatum of a mouse model of Huntington’s disease (HD) and a gene therapy aproach to induce the expression of CYP46A1 is suggested as a potential treatment for HD (77).